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Summary Objective: Gun factory workers are exposed to many solvents (toluene,
acetone, butanol, xylene, benzene, trichloroethylene). We investigated whether
chronic exposure to solvents had adverse effect on respiratory system.
Material and methods: The workers were questionnaired by modified Medical
Research Council’s respiratory questionnaire before morning start shift. Then physical
examination and measurement of pulmonary functions by portable dry rolling
spirometer were performed. The study group consisted of 1091 gun factory workers.
The workers were grouped according to their smoking habits (smokers, [exposed n:
353 vs. unexposed n: 339] and non-smokers [exposed n: 58 vs. unexposed n: 341]).
Asthma-related symptoms were defined as either definite asthma, probable asthma,
and possible asthma.
Results: In non-smokers, the report of asthma-related symptoms was more
prevalent in exposed workers than unexposed (39.7% vs. 21.7% OR 2.4[1.3–4.3],
respectively P ¼ 0:003). In smokers, the report of asthma-related symptoms was more
common in exposed group than unexposed (50.7% vs. 42.5% OR 1.4[1.0–1.9],
respectively P ¼ 0:03). Logistic regression analysis showed that smoking (OR 2.8
[2.0–3.8] P ¼ 0:00001) and exposure to solvents (OR 1.4[1.1–1.9] P ¼ 0:01) were
independent risk factors for asthma-related symptoms, after adjusting for age.
Logistic regression analysis identified that smoking (OR 3.3[2.3–4.6] P ¼ 0:00001) was
independent risk factors for chronic bronchitis. Multiple linear regression analysis of
lung-function parameters (% forced expiratory volume (FEV1), FEV1/forced vital
capacity, FEF25–75) indicated significant effects of smoking.
Conclusion: Present study indicated significant effects of smoking and exposure to
solvents, with the smoking effect being the most important on asthma-related
symptoms of gun factory workers.
& 2003 Elsevier Ltd. All rights reserved.
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Introduction
Exposures to solvents are common in both indus-
trialized and industrializing countries because of
their wide usages.1 It is well known that exposure
to organic solvents produces central nervous
system toxicity,2,3 hepatic,4 renal5 and dermatolo-
gic damage,6 but the respiratory effects of solvent
exposure are poorly investigated. Studies on
animals have also demonstrated that exposure to
solvents had adverse effects in the respiratory
system.7–9 A number of population-based studies
have showed a significant association of occupational
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solvent exposure with respiratory symptoms, im-
paired pulmonary function, but analysis of
these studies is limited by self-reported exposure
data.10–12 Solvents are implicated as causative
agents for occupational asthma in a few stu-
dies.13,14 It is well known that irritant-induced
asthma can be produced by high-level uninten-
tional respiratory irritant exposures at work or
outside the workplace.15 However, lower levels of
exposure to respiratory irritants at work are more
common, but there are little studies that deter-
mine the airway effects of such exposures.
Gun factory workers are exposed to many
solvents. We investigated whether long-term low-
level exposures to solvents had adverse effect on
respiratory system.
Materials and methods
There were 2350 male workers in different sections
in the gun factory. The study was performed on a
total of 1091 workers splitted into two groups as
exposed to only solvents and non-exposed (control
group) who work on assistance sections such as
security, office and departments related to engi-
neering. In the study, we excluded workers such as,
welders, carpenters, lathe operators, etc. In this
factory, gun pieces are produced from raw materi-
als in workshops. These produced pieces are
cleaned with solvents and workers are exposed to
toluene, acetone, butanol, xylene, benzene and
trichloroethylene during their work shift (continu-
ally 8 h/day, 5 day on a week).
All the workers were grouped according to their
smoking habits as smokers and non-smokers. Each
of these groups was separated into two subgroups
as exposed and non-exposed workers according to
the exposure to solvents. Smokers also consisted of
ex-smokers and current smokers. Chronic respira-
tory symptoms were recorded using a modified
British Medical Research Council questionnaire on
respiratory symptoms, during the morning work
shift.16 In all workers, a detailed occupational
history, as well as questions about their smoking
habits, were recorded. Chronic bronchitis were
defined as cough and phlegm for a minimum of 3
months a year and for not less than 2 successive
years.
Asthma definitions: For the purposes of this
study, ‘‘definite asthma’’ was defined as positive
responses to all three of these questions (ATS
questions 20A, 20B, and 20C3): (1) ‘‘Have you ever
had asthma?’’ (2) ‘‘Do you still have it?’’; and (3)
‘‘Was it confirmed by a doctor?’’.
‘‘Probable asthma’’ was defined as positive
responses to both of the following questions:
(1) ‘‘Have you had wheezing or whistling in your
chest at any time during the last 12 months?’’
(2) ‘‘Have you felt chest tightness or been breath-
less when the wheezing noise was present?’’ This
category excludes those with a current asthma
diagnosis, as defined above. ‘‘Possible asthma’’ was
defined as a positive response to the question,
‘‘Have you had wheezing or whistling in your chest
at any time during the last 12 months?’’ and a
positive response to one of the following two
questions: (1)’’These breathing symptoms were
brought on or made worse by exposure to any one
of the following: exercise or exertion; dust, smoke,
or fumes?’’; and (2) ‘‘Do you often wake up several
times a night with trouble breathing or coughing?’’
This category of probable asthma excludes those
with definite or possible asthma.17
Asthma-related symptoms were defined as either
definite asthma, probable asthma, and possible
asthma.
For the purposes of subsequent analyses, workers
with at least one of these asthma-related respira-
tory symptoms (yes/no) or chronic bronchitis (yes/
no) were grouped separately.
Study subjects took the spirometric tests in
the standing position. Each worker was instructed
how to take the pulmonary function test, before
the test. Spirometric tests were performed by
portable dry rolling (MIR spirobank ITALY). Maximal
expiratory flow-volume (MEFV) curves were re-
corded. On these MEFV curves, the forced vital
capacity (FVC), 1-s forced expiratory volume
(FEV1), and mean maximum flow rates at 50% and
the last 25% of the vital capacity were measured.
The percentage of predicted value for each spiro-
metric value was calculated according to the
worker’s age, sex, weight and height. Measure-
ments were performed during the morning work
shift.
The chi-square test (or, when appropriate, Fish-
er’s exact test), was used for testing differences in
the prevalence of respiratory symptoms between
groups. Prevalence odds ratios (ORs) (and their 95%
confidence intervals (95% CIs)) were calculated
with the Mantel–Haenszel method.
Logistic regression was used to calculate OR and
95% CI for the association between other respira-
tory symptoms (no¼ 0; yes¼ 1) or asthma-related
symptoms (no¼ 0; yes¼ 1) with smoking (never
smoked¼ 0; former/current smokers¼ 1), expo-
sure (no¼ 0; yes¼ 1) and age (median¼ 42 yr,
young o42; oldX42).
Results of ventilatory capacity tests were ana-
lyzed by applying a multiple regression analysis
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with age, exposure, and smoking as predictors, and
FVC, FEV1 and FEF25–75 as criteria variables.
For comparisons of continuous variables a t-test
was performed. A P value o0.05 was considered
significant.
Results
Table 1 presents the prevalences of chronic
respiratory symptoms in the non-smoker workers.
In non-smokers, there were significantly higher
prevalences for asthma-related symptoms in ex-
posed, compared with unexposed workers
(P ¼ 0:002).
Table 2 presents the prevalences of chronic
respiratory symptoms in the smoker workers. In
smokers, there were significantly higher preva-
lences for asthma-related symptoms in exposed,
compared with unexposed workers (P ¼ 0:03).
Table 3 presents the logistic regression analysis
for chronic respiratory symptoms. Logistic regres-
sion analysis showed that smoking and exposure to
solvents were independent risk factors for asthma-
related symptoms, after adjusting for age. Logistic
regression analysis identified that smoking was
independent risk factor for chronic bronchitis.
Table 4 shows the findings of multiple regression
analysis with exposure and smoking as predictors,
and lung-function parameters as outcome variables.
This table shows smoking to be a highly sig-
nificant predictor of FEV1, FEV1/FVC, and FEF25–75.
Exposure was not a significant predictor for any of
the parameters.
Lung-function parameters in groups and in sub-
groups were presented in Table 5.
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Table 1 Characteristics and respiratory symptoms of workers according to exposure in nonsmokers.
Nonsmokers OR 95% CI P value
Exposed Unexposed
n: 58 n: 341
Mean age 40.677.3n 39.1710.1
Exposure duration (yr) 16.977.9(1-33) 0
Asthma-related symptoms 23 (40.4)w 74 (21.7) 2.4 1.4–4.4 0.002
Chronic bronchitis 12 (20.7) 47 (13.8) 1.6 0.8–3.3 NSz
nValues are mean7standard deviation.
wValues are percentages, with the number of subjects in parentheses.
zNS, not significant.
Table 3 Respiratory symptoms in relation to age exposure, and smoking in all subjectsFlogistic procedures.
OR, smoking 95% CI P value OR, exposure 95% CI P value
Asthma-related symptoms 2.8 2.0–3.8 0.00001 1.4 1.1–1.9 0.01
Chronic bronchitis 3.3 2.3–4.6 0.00001 NS
Table 2 Characteristics and respiratory symptoms of workers according to exposure in smokers.
Smokers OR 95% CI P value
Exposed Unexposed
n: 353 n: 339
Mean age 40.876.7 41.377.6 NSn
Cigarette pack-year 15.6712.1 16.1711.7
Exposure duration (yr) 16.477.1(1–30) 0
Asthma-related symptoms 179 (50.7)w 144 (42.5) 1.4 1.0–1.9 0.003
Chronic bronchitis 153(43.3) 138(40.7) 1.1 0.8–1.5 NS
nNS: not significant.
wValues are percentages, with the number of subjects in parentheses.
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In smokers, the ratio of current smoker was not
different between exposed and unexposed sub-
groups (71.8%, 75.5% P40:05).
The mean cigarette pack-years of current smo-
kers was not different between exposed and un-
exposed subgroups (14.470.7, 14.670.6 P40:05).
The mean cigarette pack-years of ex-smokers
were not different between exposed and unex-
posed subgroups (4.870.5, 4.370.4 P ¼ 0:479).
The pulmonary functions in smokers did not
differ significantly between exposed and unexposed
subgroups.
The prevalence of chronic cough (18.8% vs. 6.5%
P ¼ 0:0001), chronic bronchitis (38.0% vs. 15.8%
P ¼ 0:0001), possible asthma (39.5% vs. 16.1%
P ¼ 0:0001), dyspnea (47.9% vs. 29.5% P ¼ 0:0001)
in smokers was higher than non-smokers.
The mean FEV1% value of smokers was lower
than those of the non-smokers (97.2714.7 vs.
101.9713.20 P ¼ 0:0001).
Discussion
Asthma-related symptoms in exposed groups of
non-smokers and smokers were more common than
control groups. The higher prevalence of asthma-
related symptoms among exposed groups may be a
result of the sensitizer effect of these solvents. A
logistic regression analysis performed on asthma-
related symptoms of gun factory workers indicated
significant effects of smoking and exposure, with
the smoking effect being the most important.
However, logistic process showed only significant
effects of smoking on chronic bronchitis.
Studies have demonstrated that solvents cause
mucosal irritation of the eyes and upper airways,
but the respiratory effects of solvent exposure
were poorly documented.1 Lee et al.18 found that
the newspaper pressworkers who were exposed to
solvents had significantly more respiratory symp-
toms than control group, even though the degree of
exposure was within the current permissible ex-
posure limits. Zuskin et al.19 also found that the
high prevalence of respiratory symptoms was
primarily a consequence of exposure to the
numerous organic solvents found in the work-place
in the leather shoe manufacturing industry. Wies-
lander et al.20 indicated that exposure to solvent-
based paint might cause an increase in respiratory
symptoms among painters but water-based paint
did not. Talini et al.21 found that spray painters
exposed to low concentration of diisocyanates and
solvents had higher prevalence of chronic cough
than control, and a trend in increasing the
prevalence of shortness of breath with wheeze,
dyspnea, and asthma. Paggiaro et al.22 showed that
occupational exposure to organic solvents might
cause chronic airway impairment with non-specific
bronchial hyper-responsiveness in three shoe fac-
tory workers. In line to ours, above studies
demonstrated that chronic exposure to solvents
may cause adverse effects on respiratory system. In
contrast, Akbar-Khanzadeh and Rivas23 showed that
no significant difference was in proportion of
respiratory symptoms between the solvent-exposed
group and non-exposed group in polyurethane
molding process workers.
Multiple linear regression analysis of lung-func-
tion parameters indicated significant effects of
smoking, but not exposure. According to this, it
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Table 4 Regression analysis of ventilatory capa-
city tests in all workers.
P value R2
FEV1%
Intercept 0.0001 0.034
Exposure NS
Smoking 0.0001
FEV1/FVC
Intercept 0.0001 0.033
Exposure NS
Smoking 0.0001
MMF%
Intercept 0.0001 0.030
Exposure NS
Smoking 0.0001
Table 5 Ventilatory capacity measurements of workers according to exposure.
Nonsmokers Smokers
Exposed Unexposed P value Exposed Unexposed P value
n: 58 n: 341 n: 353 n: 339
FEV1% 102.2710.8 100.9713.3 NS 97.5715.5 96.4714.6 NS
FEV1/FVC 83.774.9 84.376.7 NS 81.9077.4 82.177.3 NS
MMF 103.8724.6 102.7729.3 NS 93.88728.2 94.2729.0 NS
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suggests that smoking has more important effect
than exposure on pulmonary function in workers.
Similarly, the spirometric results in newspaper
pressroom workers did not significantly differ
between the exposed to solvent and control group
(both group have the same cigarette pack-year).18
The difference in pulmonary function was not
observed between non-exposed subjects and those
exposed only to organic solvents in workers in a
polyurethane molding process.23 In contrast, the
measured ventilatory capacity values in exposed
workers to solvents were significantly lower
in comparison to control in shoe manufacturing
workers.19
Provided that we had evaluated the atopy and
bronchial hyper-responsiveness in workers and
measured the concentrations of the chemical
irritants in the environment would be better for
an improved assessment. Besides, effects on
respiratory systems of exposure to solvents should
be more investigated with longitudinal studies in
larger groups.
Present study suggests that chronic exposure to
solvents may cause increase in asthma-related
symptoms. In order to prevent respiratory disorders
among gun factory workers, we suggest that,
medical observation, including pre-employment
and periodic medical controls, should be performed
and should include pulmonary function tests. This
medical screening can protect workers from devel-
oping chronic respiratory disorders by allowing the
early recognition and possibly the removal of
sensitive workers from the working place before
chronic impairment develops.
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